相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The effects of cannabis, cannabinoids, and their administration routes on pain control efficacy and safety: A systematic review and network meta-analysis
Karma Rabgay et al.
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION (2020)
Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review
Jerome Sarris et al.
BMC PSYCHIATRY (2020)
The effects of acute and sustained cannabidiol dosing for seven days on the haemodynamics in healthy men: A randomised controlled trial
Salahaden R. Sultan et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2020)
Adjunctive Cannabidiol in Patients with Dravet Syndrome: A Systematic Review and Meta-Analysis of Efficacy and Safety
Simona Lattanzi et al.
CNS DRUGS (2020)
Efficacy and adverse event profile of cannabidiol and medicinal cannabis for treatment-resistant epilepsy: Systematic review and meta-analysis
Renandro de Carvalho Reis et al.
EPILEPSY & BEHAVIOR (2020)
Abrupt withdrawal of cannabidiol (CBD): A randomized trial
Lesley Taylor et al.
EPILEPSY & BEHAVIOR (2020)
Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome A Randomized Clinical Trial
Ian Miller et al.
JAMA NEUROLOGY (2020)
The Effectiveness of Cannabinoids in the Treatment of Posttraumatic Stress Disorder (PTSD): A Systematic Review
C. Hindocha et al.
JOURNAL OF DUAL DIAGNOSIS (2020)
How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review
Eva Hoch et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2019)
Is cannabidiol the ideal drug to treat non-motor Parkinson's disease symptoms?
Jose Alexandre S. Crippa et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2019)
Drug-drug interactions between antiepileptics and cannabinoids
Barbara Miziak et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2019)
Efficacy, tolerability and safety of cannabis-based medicines for cancer pain A systematic review with meta-analysis of randomised controlled trials
Winfried Haeuser et al.
SCHMERZ (2019)
The Potential of Cannabidiol as a Treatment for Psychosis and Addiction: Who Benefits Most? A Systematic Review
Albert Batalla et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review
Laura Orsolini et al.
MEDICINA-LITHUANIA (2019)
Cannabis-based products for pediatric epilepsy: A systematic review
Jesse Elliott et al.
EPILEPSIA (2019)
A Phase 1, Open-Label, Pharmacokinetic Trial to Investigate Possible Drug-Drug Interactions Between Clobazam, Stiripentol, or Valproate and Cannabidiol in Healthy Subjects
Gilmour Morrison et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2019)
Cannabidiol as a potential treatment for psychosis
Cathy Davies et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2019)
The Potential for Pharmacokinetic Interactions Between Cannabis Products and Conventional Medications
Yuli Qian et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2019)
Benefits and harms of medical cannabis: a scoping review of systematic reviews
Misty Pratt et al.
SYSTEMATIC REVIEWS (2019)
Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis
Nicola Black et al.
LANCET PSYCHIATRY (2019)
Efficacy, tolerability and safety of cannabis-based medicines for chronic pain management - An overview of systematic reviews
W. Haeuser et al.
EUROPEAN JOURNAL OF PAIN (2018)
Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial
Philip McGuire et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence
Emily Stockings et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
Elizabeth A. Thiele et al.
LANCET (2018)
Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome
Orrin Devinsky et al.
NEUROLOGY (2018)
Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome
Orrin Devinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial
Douglas L. Boggs et al.
PSYCHOPHARMACOLOGY (2018)
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
Lesley Taylor et al.
CNS DRUGS (2018)
Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-Analysis
Simona Lattanzi et al.
DRUGS (2018)
Interactions between cannabidiol and commonly used antiepileptic drugs
Tyler E. Gaston et al.
EPILEPSIA (2017)
Medical Cannabinoids in Children and Adolescents: A Systematic Review
Shane Shucheng Wong et al.
PEDIATRICS (2017)
Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders
Alline C. Campos et al.
FRONTIERS IN PHARMACOLOGY (2017)
A Systematic Review of the Effectiveness of Medical Cannabis for Psychiatric, Movement and Neurodegenerative Disorders
Keane Lim et al.
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2017)
Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn's Disease, a Randomized Controlled Trial
Timna Naftali et al.
DIGESTIVE DISEASES AND SCIENCES (2017)
An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies
Kerstin Iffland et al.
CANNABIS AND CANNABINOID RESEARCH (2017)
Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study
Khalid A. Jadoon et al.
DIABETES CARE (2016)
A Systematic Review of the Evidence for Medical Marijuana in Psychiatric Indications
Samuel T. Wilkinson et al.
JOURNAL OF CLINICAL PSYCHIATRY (2016)
Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review
Nora D. Volkow et al.
JAMA PSYCHIATRY (2016)
Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy
Alexandra L. Geffrey et al.
EPILEPSIA (2015)
Cannabinoids for Medical Use A Systematic Review and Meta-analysis
Penny F. Whiting et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems A Clinical Review
Kevin P. Hill
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Endocannabinoid signaling at the periphery: 50 years after THC
Mauro Maccarrone et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Effects of cannabidiol in the treatment of patients with Parkinson's disease: An exploratory double-blind trial
Marcos Hortes N. Chagas et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2014)
Programming of neural cells by (endo) cannabinoids: from physiological rules to emerging therapies
Mauro Maccarrone et al.
NATURE REVIEWS NEUROSCIENCE (2014)
Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders Report of the Guideline Development Subcommittee of the American Academy of Neurology
Barbara S. Koppel et al.
NEUROLOGY (2014)
Valproic acid pathway: pharmacokinetics and pharmacodynamics
Yogita Ghodke-Puranik et al.
PHARMACOGENETICS AND GENOMICS (2013)
Acute Effects of a Single, Oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) Administration in Healthy Volunteers
R. Martin-Santos et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
F. M. Leweke et al.
TRANSLATIONAL PSYCHIATRY (2012)
Safety and Side Effects of Cannabidiol, a Cannabis sativa Constituent
Mateus Machado Bergamaschi et al.
CURRENT DRUG SAFETY (2011)
Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
Sagnik Bhattacharyya et al.
NEUROPSYCHOPHARMACOLOGY (2010)
分享论文
